Axsome Therapeutics, Inc vs Abbvie Inc.
AXSM vs ABBV — side-by-side comparison from reported financials. AXSM leads 4, ABBV leads 5 of 9 comparable metrics.
Axsome Therapeutics, Inc
AXSM · Healthcare
$168.52-0.92%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | AXSM | ABBV |
|---|---|---|
| Price | $168.52 | $276.43 |
| Market cap | $8.83B | $488B |
| Revenue (TTM) | $777M | $64.4B |
| Revenue growth | +133.7% | +1.8% |
| Net margin | -24.7% | 9.8% |
| Free cash flow | -$72.0M | $18.2B |
| Net cash (debt) | $205M | ($56.2B) |
| 1-year price return | +37.5% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | — | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -256% | 96% |
| Altman Z-score | 5.42 | 2.33 |
| CV checks passed | 5 of 9 | 9 of 9 |
| Employees | 925 | 57,000 |
Full résumé-style profiles: AXSM CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.